Article

LASIK platforms perform well with minor differences

New Orleans—Separate prospective comparison studies of LASIK platforms have shown that the systems evaluated produced similarly successful outcomes with relatively minor differences. According to speakers at a refractive surgery session at the American Academy of Ophthalmology meeting, these studies also represent a welcome trend toward head-to-head comparisons of the various platforms and a step toward expanding evaluation criteria.

In the first study presented, a randomized, prospective, masked comparison of four excimer laser systems used in conventional LASIK, investigators found that all performed well with subtle differences in contrast acuity and refractive stability, said Steven C. Schallhorn, MD, director of cornea and refractive surgery, Naval Medical Center, San Diego.

However, there were differences in stability, contrast acuity, treatment diameter, ablation depth, and ergonomics, he added.

A nomogram adjustment group of 20 patients treated with each laser was evaluated at 1 month to determine whether the nomograms provided by the laser companies required adjustment. No adjustments were necessary, and these patients were included in the data analyzed for the study, Dr. Schallhorn said.

Subsequently, 400 additional patients were treated, 100 with each laser.

Dr. Schallhorn reported that a "glitch" occurred at this point in the study.

"Following completion of the treatments, an error was discovered. A minor, routine software upgrade altered the routine nomogram. One primary cohort had undercorrection by 8%. All laser companies were told of the situation but not which laser was involved. They all agreed to a redo of the primary cohort for the affected laser," he explained.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.